Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding variants of ambiguous significance for human health. Computational tools are needed to accelerate the identification of specific variants and genes that contribute to human disease. Results We have developed the Variant Effect Scoring Tool (VEST), a supervised machine learning-based classifier, to prioritize rare missense variants with likely involvement in human disease. The VEST classifier training set comprised ~ 45,000 disease mutations from the latest Human Gene Mutation Database release and another ~45,000 high frequency (allele frequency > 1%) putatively neutral missense variants from the Exome Sequencing Project. VEST outperfor...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding v...
Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding v...
Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding v...
Background: Whole exome sequencing studies identify hundreds to thousands of rare protein coding var...
New sequencing technology has enabled the identification of thousands of single nucleotide polymorph...
Many sequencing studies are now underway to identify the genetic causes for both Mendelian and compl...
The interpretation of non-coding variants still constitutes a major challenge in the application of ...
Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identif...
Here we present an exome-wide rare genetic variant association study for 30 blood biomarkers in 191,...
Purpose: Whole exome and genome sequencing have transformed the discovery of genetic variants that c...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding v...
Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding v...
Background Whole exome sequencing studies identify hundreds to thousands of rare protein coding v...
Background: Whole exome sequencing studies identify hundreds to thousands of rare protein coding var...
New sequencing technology has enabled the identification of thousands of single nucleotide polymorph...
Many sequencing studies are now underway to identify the genetic causes for both Mendelian and compl...
The interpretation of non-coding variants still constitutes a major challenge in the application of ...
Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identif...
Here we present an exome-wide rare genetic variant association study for 30 blood biomarkers in 191,...
Purpose: Whole exome and genome sequencing have transformed the discovery of genetic variants that c...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...
Across a variety of Mendelian disorders, similar to 50-75% of patients do not receive a genetic diag...